Viracta Therapeutics Inc (VIRX)

$0.04 -0.04 (-54.76%)
Market Cap 3.09M
Revenue (ttm) 0.00
Net Income (ttm) -51.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -2.55
Volume 4,713,400
Avg Vol 2,877,370
Day's Range N/A - N/A
Shares Out 39.74M
Stochastic %K 1%
Beta 0.70
Analysts Sell
Price Target $2.50

Company Profile

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. The company's lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. It's Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of r...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 400 8470
Address:
2533 South Coast Highway 101, Suite 210, Cardiff, United States
DYL2025
DYL2025 Sep. 17 at 5:15 PM
$VIRX A new study from Mass General Brigham, published in Nature Medicine, found that Epstein-Barr virus (EBV) activity increases before MS relapses and may interact with genetic risk factors to trigger disease activity. http://spklr.io/6187ETdxR
1 · Reply
DYL2025
DYL2025 Aug. 15 at 1:30 AM
$VIRX hope is alive ...? https://pubmed.ncbi.nlm.nih.gov/42517423/
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 10 at 1:27 PM
$VIRX 1 post per quarter here or what ?
1 · Reply
PenkeInvesting
PenkeInvesting Jun. 30 at 5:19 AM
Fundamental analysis of $VIRX (Viracta Therapeutics, Inc.) based on financial data and reported results. #VIRX #Viracta
0 · Reply
DYL2025
DYL2025 May. 16 at 2:27 PM
$VIRX Can some company take over Viracta and run basket trial(s) with said diseases like lupus, MS, etc. ? Maybe this drug can help during flares? The combined market should be quite sizable.
0 · Reply
DYL2025
DYL2025 Feb. 11 at 4:27 PM
$VIRX EBV causes autoimmune diseases like lupus and MS, not just cancer. nanatinostat combo regimen may have potential role in these indications. big pharma with deep pocket should acquire viracta.
1 · Reply
Eurydice
Eurydice Dec. 24 at 11:48 PM
$VIRX Merry Chirstmas to Mark Rothera and Treefrog Therapeutics. I hope Treefrog investors have a better outcome than Viracta.
1 · Reply
Godwins26
Godwins26 Oct. 16 at 4:05 PM
$EPWK $GNPX $TOVX $ADAPY $VIRX
1 · Reply
Godwins26
Godwins26 Oct. 15 at 5:16 PM
Watchlist for today 😊 $EPWK $GNPX $TOVX $ADAPY $VIRX
0 · Reply
Eurydice
Eurydice Sep. 25 at 4:35 PM
$VIRX 🖕
0 · Reply
Latest News on VIRX
No data available.
DYL2025
DYL2025 Sep. 17 at 5:15 PM
$VIRX A new study from Mass General Brigham, published in Nature Medicine, found that Epstein-Barr virus (EBV) activity increases before MS relapses and may interact with genetic risk factors to trigger disease activity. http://spklr.io/6187ETdxR
1 · Reply
DYL2025
DYL2025 Aug. 15 at 1:30 AM
$VIRX hope is alive ...? https://pubmed.ncbi.nlm.nih.gov/42517423/
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 10 at 1:27 PM
$VIRX 1 post per quarter here or what ?
1 · Reply
PenkeInvesting
PenkeInvesting Jun. 30 at 5:19 AM
Fundamental analysis of $VIRX (Viracta Therapeutics, Inc.) based on financial data and reported results. #VIRX #Viracta
0 · Reply
DYL2025
DYL2025 May. 16 at 2:27 PM
$VIRX Can some company take over Viracta and run basket trial(s) with said diseases like lupus, MS, etc. ? Maybe this drug can help during flares? The combined market should be quite sizable.
0 · Reply
DYL2025
DYL2025 Feb. 11 at 4:27 PM
$VIRX EBV causes autoimmune diseases like lupus and MS, not just cancer. nanatinostat combo regimen may have potential role in these indications. big pharma with deep pocket should acquire viracta.
1 · Reply
Eurydice
Eurydice Dec. 24 at 11:48 PM
$VIRX Merry Chirstmas to Mark Rothera and Treefrog Therapeutics. I hope Treefrog investors have a better outcome than Viracta.
1 · Reply
Godwins26
Godwins26 Oct. 16 at 4:05 PM
$EPWK $GNPX $TOVX $ADAPY $VIRX
1 · Reply
Godwins26
Godwins26 Oct. 15 at 5:16 PM
Watchlist for today 😊 $EPWK $GNPX $TOVX $ADAPY $VIRX
0 · Reply
Eurydice
Eurydice Sep. 25 at 4:35 PM
$VIRX 🖕
0 · Reply
Eurydice
Eurydice Aug. 15 at 4:04 PM
$VIRX 🖕
0 · Reply
Stormra
Stormra Jul. 18 at 2:24 PM
$VIRX So what happens now with our shares??
1 · Reply
Eurydice
Eurydice Jul. 17 at 4:02 PM
$VIRX is it finally done trading? no volume today.
0 · Reply
Stormra
Stormra Jul. 17 at 1:16 PM
$VIRX I got screwed AGAIN.
0 · Reply
Eurydice
Eurydice Jul. 15 at 5:37 PM
$VIRX what’s with the spike in volume
0 · Reply
Eurydice
Eurydice Jun. 21 at 10:18 PM
$VIRX nice job Mark!
0 · Reply
Eurydice
Eurydice Jun. 16 at 7:14 PM
$VIRX 🖕viracta
0 · Reply
stephllllll
stephllllll Jun. 10 at 2:45 PM
$VIRX Bigger volume than usual...what's going on?
0 · Reply
Eurydice
Eurydice Jun. 10 at 12:19 PM
$VIRX Why is this stock still trading since the company has shut down?
1 · Reply
Eurydice
Eurydice Apr. 18 at 11:19 PM
$VIRX Please pardon my ignorance but why does a stock continue to trade under these circumstances? who is buying the shares? do companies ever come out of a wind down?
1 · Reply
BrexitIsStupid
BrexitIsStupid Apr. 18 at 9:00 AM
$VIRX
0 · Reply